Ascendis Pharma is applying our innovative TransCon technology platform to build a leading, fully integrated biopharmaceutical company focused on making a meaningful difference in patients’ lives. Guided by our core values of patients, science and passion, we utilize our TransCon technology platform to create new and potentially best-in-class therapies. Ascendis Pharma currently has three independent endocrinology rare disease product candidates in clinical development and we're also advancing programs in Oncology and Ophthalmology. Ascendis Pharma is headquartered in Copenhagen, Denmark, with additional offices in Heidelberg, Munich, and Berlin, Germany, Palo Alto and Redwood City, California, and Princeton, New Jersey.
View Top Employees from Ascendis PharmaWebsite | http://www.ascendispharma.com |
Ticker | ASND |
Revenue | $14.6 million |
Funding | $108 million |
Employees | 904 (892 on RocketReach) |
Founded | 2007 |
Phone | (457) 022-2244 |
Fax | (453) 694-4010 |
Technologies |
JavaScript,
HTML,
PHP
+45 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Healthcare, Science and Engineering, Drug Discovery, Clinical Trials, Health Care |
Web Rank | 3 Million |
Keywords | Pharmaceutical Biotechnology, Genetic Testing |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Ascendis Pharma employee's phone or email?
The Ascendis Pharma annual revenue was $14.6 million in 2024.
Lars Pettersson is the CIO of Ascendis Pharma.
892 people are employed at Ascendis Pharma.
The NAICS codes for Ascendis Pharma are [3254, 32541, 32, 325].
The SIC codes for Ascendis Pharma are [28, 283].